ArticleMolecular cancer therapeutics2010

Activity of the Aurora kinase inhibitor VX-680 against Bcr/Abl-positive acute lymphoblastic leukemias.

Fei Fei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.